iStent
DeviceGlaucoma Surgery
Other names: Glaukos iStent
NCT Number: NCT00326014
To evaluate the safety and efficacy of a new trabecular bypass that is implanted in conjunction with cataract surgery in open angle glaucoma subjects.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Klinik Vincentinum, Augsburg, Germany
Glaukos Corporation conducted a clinical research study at multiple investigational sites within Europe (8)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Glaucoma Surgery
Other names: Glaukos iStent
Time frame: 24 months
Glaukos Corporation
Industry
A Study of the Glaukos Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00326066
Cataract, Eye Diseases
Vienna, Austria
View Trial DetailsNCT00323284
Cataract, Eye Diseases
Beverly Hills, California, United States
View Trial DetailsNCT00721968
Cataract, Eye Diseases
View Trial DetailsNCT05411198
Eye Diseases, Glaucoma
Fayetteville, Arkansas, United States
View Trial Details